New Rhein Healthcare Investors
Robert Czesak currently serves as the Chief Financial Officer at New Rhein Healthcare Investors, a position held since June 2022. Prior experience includes serving as Controller at HealthCare Royalty Partners from November 2017 to June 2022, and Managing Director at Broadscope Fund Administrators from September 2015 to October 2017. Robert also held the role of Senior Accounting Manager at SS&C Technologies from July 2008 to August 2015, and was a Fund Accountant at Credit Suisse from April 2003 to May 2008. Robert Czesak earned a Bachelor of Science degree in Finance from The College of New Jersey between 1999 and 2003.
This person is not in any teams
This person is not in any offices
New Rhein Healthcare Investors
New Rhein is a Venture Capital/ Private Equity investor. Its partners are former pharmaceutical industry executives having both operational and M&A experience. New Rhein invests in healthcare companies with the objective of helping management teams build their business into a profile strategic investors would find attractive. We use our knowledge of what strategic buyers want and our relationships to help our portfolio companies achieve this goal. Investment areas of focus include specialty Rx (eg hospital), branded and difficult to make Gx, OTC, biologics, vaccines, and emerging markets (in particular China and Brazil). We are interested in product only deals, carve-outs and entire company purchases.